Mono Pharmacare Limited (NSE:MONOPHARMA)
India · Delayed Price · Currency is INR 8.95
0.00 (0.00%)
Sep 10, 2026, 3:19 PM IST
Mono Pharmacare Revenue
In the fiscal year ending March 31, 2026, Mono Pharmacare had annual revenue of 1.66B INR, down -1.62%. Mono Pharmacare had revenue of 994.15M in the half year ending March 31, 2026, with 77.94% growth.
Revenue
1.66B
Revenue Growth
-1.62%
P/S Ratio
0.10
Revenue / Employee
n/a
Employees
115
Market Cap
158.13M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.66B | -27.28M | -1.62% |
| Mar 31, 2025 | 1.68B | 460.68M | 37.65% |
| Mar 31, 2024 | 1.22B | 892.22M | 269.20% |
| Mar 31, 2023 | 331.44M | -39.50M | -10.65% |
| Mar 31, 2022 | 370.93M | 87.15M | 30.71% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 599.11B |
| Apollo Hospitals Enterprise | 264.30B |
| Divi's Laboratories | 112.30B |
| Lenskart Solutions | 96.34B |
| Mohini Health & Hygiene | 1.44B |
| Vivimed Labs | 763.08M |
| Sunrest Lifescience | 708.33M |
| Nidan Laboratories and Healthcare | 255.42M |